Abstract:We studied the clinicopathological and imaging characteristics of primary central nervous system diffuse large B-cell lymphomas (PCNS-DLBCL). Imaging, pathologic histology, and immunohistochemical staining characteristics were analyzed, and the immunoglobulin heavy and light chain gene rearrangement of 25 PCNS-DLBCL cases was examined. MicroRNA was extracted from 10 cases each of PCNS-DLBCL, extracerebral germinal center DLBCL (GC-DLBCL), and extracerebral non-GC-DLBCL (NGC-DLBCL); we conducted chip hybridization and comparatively analyzed the difference among the three. PCNS-DLBCLs typically involved no less than two cerebral lobes (10/25); the frontal lobe was affected most often (6/25). Target-shaped structures were observed in all PCNS-DLBCLs due to the proliferation of centroblast-like large lymphocytes surrounding the vessels. There was strong and diffuse immunostaining for CD20 and CD79a, and negative immunostaining for CD3, CD5, CD23, and cyclin D1 for all PCNS-DLBCLs. The percentage of cells with nuclear positivity for anti-Ki67 antibody ranged 50-90% (mean, 80%). Three, 19, and 22 PCNS-DLBCLs were CD10-, Bcl-6-, and melanoma ubiquitous mutated 1-positive, respectively. Twenty-four PCNS-DLBCLs were B-cell monoclonal. MicroRNA hybridization showed that 788 PCNS-DLBCL microRNAs/segments increased to at least twice that of NGC-DLBCLs, and 401 PCNS-DLBCL microRNAs/segments declined to less than half of that of NGC-DLBCLs. Six hundred and eleven PCNS-DLBCL microRNAs/segments increased to at least twice that of GC-DLBCLs, and 229 PCNS-DLBCL microRNAs/segments declined to less than half of that in GC-DLBCLs. PCNS-DLBCL typically affected multiple sites, tended to occur in older men, arose from activated B cells, had high B-cell monoclonality; its microRNA expression differed from that of NGC-DLBCL and GC-DLBCL.

Study of the molecule subtype of primary central nervous system lymphoma with their clinical pathology

The Potential Role of Ku80 in Primary Central Nervous System Lymphoma As a Prognostic Factor.

Subtyping of Primary Gastrointestinal Diffuse Large B-cell Lymphoma

Analysis of the Immunohistochemical Subtypes and Prognosis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

[Primary Diffuse Large B-cell Lymphoma of Central Nervous System Belongs to Activated B-cell-like Subgroup: a Study of 47 Cases].

Genomic Landscape and Molecular Subtypes of Primary Central Nervous System Lymphoma

Clinicopathological Study of Gene Rearrangement and Microrna Expression of Primary Central Nervous System Diffuse Large B-Cell Lymphomas

Clinicopathologic Significance of MYD88 L265P Mutation and Expression of TLR4 and P-STAT3 in Primary Central Nervous System Diffuse Large B-cell Lymphomas

Primary Central Nervous System Diffuse Large B-cell Lymphoma Shows an Activated B-cell-like Phenotype with Co-Expression of C-MYC, BCL-2, and BCL-6.

Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.

A Retrospective Study of 40 Cases of Pathologically Established Primary Central Nervous System Lymphoma

Study of subtyping with primary diffuse large B-cell lymphoma of Waldeyer's ring

Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System

Prognostic Value of Clinical Characteristics and Immunophenotypic Biomarkers in 115 Patients with Primary Central Nervous System Lymphoma.

Primary lymphoma of the central nervous system: a clinicopathologic study

[Clinical Study of P-gp, and Bcl-2 Protein Expression in Non-Hodgkin's Lymphomas Patients].

Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase Inhibitors

Primary central nervous system lymphoma: a series report and literature review

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.

Role of Cerebrospinal Fluid Cytology in Diagnosis of Primary Central Nervous System Lymphoma